Trial Profile
A Multiple-Dose, Randomized, Double-Blind, Placebo- and Active-Controlled, Four-Arm, Parallel Group Thorough QT/QTc Study to Evaluate the Electrophysiologic Effects of Sativex
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2022
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary) ; Moxifloxacin
- Indications Pain
- Focus Therapeutic Use
- Sponsors Jazz Pharmaceuticals Inc
- 30 Mar 2011 New trial record